Kiniksa Pharmaceuticals to Present at Jefferies Global Healthcare Conference in London
Kiniksa Pharmaceuticals (Nasdaq: KNSA) will present at the Jefferies Global Healthcare Conference in London on Monday, November 17, 2025 at 2:30 p.m. GMT (9:30 a.m. ET). Management's presentation will be webcast live and accessible via the Investors section of Kiniksa's website at www.kiniksa.com. A replay will be posted on the company website approximately 48 hours after the event.
Kiniksa Pharmaceuticals (Nasdaq: KNSA) presenterà alla Jefferies Global Healthcare Conference a Londra lunedì 17 novembre 2025 alle ore 14:30 GMT (9:30 ET). La presentazione della direzione sarà trasmessa in diretta in webcast e accessibile tramite la sezione Investitori del sito web di Kiniksa all'indirizzo www.kiniksa.com. Una replica verrà pubblicata sul sito dell'azienda circa 48 ore dopo l'evento.
Kiniksa Pharmaceuticals (Nasdaq: KNSA) participará en la Jefferies Global Healthcare Conference en Londres el lunes 17 de noviembre de 2025 a las 14:30 GMT (9:30 ET). La presentación de la dirección se transmitirá en vivo por webcast y estará disponible a través de la sección de Inversores del sitio web de Kiniksa en www.kiniksa.com. Una réplica será publicada en el sitio de la empresa aproximadamente 48 horas después del evento.
Kiniksa Pharmaceuticals (Nasdaq: KNSA)가 런던에서 열리는 Jefferies Global Healthcare Conference에 2025년 11월 17일 월요일 오후 2시 30분 GMT(동부 표준시 9시 30분)에 발표합니다. 경영진의 발표는 라이브 webcast로 스트리밍되며 www.kiniksa.com의 투자자 섹션에서 접속 가능합니다. 이벤트 후 약 48시간 이내에 회사 웹사이트에 재방송이 게시됩니다.
Kiniksa Pharmaceuticals (Nasdaq : KNSA) sera présent à la Jefferies Global Healthcare Conference à Londres le lundi 17 novembre 2025 à 14 h 30 GMT (9 h 30 HE). La présentation de la direction sera diffusée en direct et accessible via la section Investisseurs du site Web de Kiniksa à l’adresse www.kiniksa.com. Une rediffusion sera publiée sur le site de l’entreprise environ 48 heures après l’événement.
Kiniksa Pharmaceuticals (Nasdaq: KNSA) wird auf der Jefferies Global Healthcare Conference in London am Montag, dem 17. November 2025, um 14:30 GMT (9:30 ET) präsentieren. Die Präsentation des Managements wird live gestreamt und ist über den Bereich Investors der Website von Kiniksa unter www.kiniksa.com zugänglich. Eine Wiederholung wird ca. 48 Stunden nach der Veranstaltung auf der Website des Unternehmens veröffentlicht.
شركة كينيكسا للصناعات الدوائية (ناسداك: KNSA) ستقدم في مؤتمر Jefferies Global Healthcare Conference العالمي في لندن يوم الاثنين 17 نوفمبر 2025 في الساعة 2:30 مساءً بتوقيت GMT (9:30 صباحًا بتوقيت شرق الولايات المتحدة). ستُبَث عرض الإدارة مباشرةً وستكون متاحة من خلال قسم المستثمرين في موقع كينيكسا الإلكتروني www.kiniksa.com. وسيتم نشر إعادة العرض على موقع الشركة حوالي 48 ساعة بعد الحدث.
- None.
- None.
LONDON, Nov. 12, 2025 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) today announced that management will present at the Jefferies Global Healthcare Conference in London on Monday, November 17, 2025 at 2:30 p.m. Greenwich Mean Time (9:30 a.m. Eastern Time).
A live webcast of Kiniksa’s presentation will be accessible through the Investors section of the company’s website at www.kiniksa.com. A replay of the event will also be available on Kiniksa’s website within approximately 48 hours after the event.
About Kiniksa
Kiniksa is a biopharmaceutical company dedicated to improving the lives of patients suffering from debilitating diseases by discovering, acquiring, developing, and commercializing novel therapies for diseases with unmet need, with a focus on cardiovascular indications. Kiniksa’s portfolio of assets is based on strong biologic rationale or validated mechanisms and offers the potential for differentiation. For more information, please visit www.kiniksa.com.
Every Second Counts! ®
Kiniksa Investor & Media Contact
Jonathan Kirshenbaum
(781) 829-3949
jkirshenbaum@kiniksa.com